PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis
暂无分享,去创建一个
Junbo Hu | Yaqi Chen | Zhihong Wang | Changsheng Huang | Xue-lai Luo | Feng Xu | Fuqing Hu | Da Song | Guihua Wang | Cheng Qiu | Kangdi Li | Xuling Sun | Haiteng Deng | Chongchong Zhao | Kairui Wan | Chen-Wei Yu | S. Lai | Anyi Liu | Qi Wu | Xiaowei She | Xun Li | Lang Liu | Mao Li | Xuelai Luo
[1] Yongdong Feng,et al. EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis , 2022, The Journal of clinical investigation.
[2] Tianshu Yang,et al. Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition , 2021, Cell Death & Differentiation.
[3] F. Gonzalez,et al. Myelocytomatosis‐Protein Arginine N‐Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma , 2021, Hepatology.
[4] C. Arrowsmith,et al. Protein arginine methylation: from enigmatic functions to therapeutic targeting , 2021, Nature Reviews Drug Discovery.
[5] Yongdong Feng,et al. NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein , 2021, Oncogene.
[6] Di Wu,et al. PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma , 2020, Cell Death & Disease.
[7] Z. Ronai,et al. PRMT5 function and targeting in cancer , 2020, Cell stress.
[8] R. Pearson,et al. Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma , 2019, Proceedings of the National Academy of Sciences.
[9] S. Richard,et al. The regulation, functions and clinical relevance of arginine methylation , 2019, Nature Reviews Molecular Cell Biology.
[10] F. Lyko,et al. The importance of non-histone protein methylation in cancer therapy , 2019, Nature Reviews Molecular Cell Biology.
[11] Clare C. Davies,et al. PRMTs and Arginine Methylation: Cancer's Best-Kept Secret? , 2019, Trends in molecular medicine.
[12] P. ten Dijke,et al. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis , 2019, International journal of molecular sciences.
[13] Michael L. Wang,et al. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells , 2019, Leukemia.
[14] Eduard Batlle,et al. Transforming Growth Factor-β Signaling in Immunity and Cancer. , 2019, Immunity.
[15] Shujiro Okuda,et al. SMAD4 alteration associates with invasive‐front pathological markers and poor prognosis in colorectal cancer , 2019, Histopathology.
[16] Min Gyu Lee,et al. SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis , 2018, Nature Cell Biology.
[17] Yanqiu Yuan,et al. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery. , 2018, Journal of medicinal chemistry.
[18] M. Ferrari,et al. SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy , 2018, Clinical Cancer Research.
[19] C. Deng,et al. The role of TGF-β/SMAD4 signaling in cancer , 2018, International journal of biological sciences.
[20] A. Tolcher,et al. Abstract CT038: A phase I, open-label, dose-escalation study to investigate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin's lymphoma , 2017 .
[21] B. Kessler,et al. Protein arginine methylation: a prominent modification and its demethylation , 2017, Cellular and Molecular Life Sciences.
[22] S. Richard,et al. Arginine Methylation: The Coming of Age. , 2017, Molecular cell.
[23] Xin-Hua Feng,et al. Posttranslational Regulation of Smads. , 2016, Cold Spring Harbor perspectives in biology.
[24] D. Shechter,et al. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond , 2015, Cellular and Molecular Life Sciences.
[25] Yusuke Nakamura,et al. Critical roles of non-histone protein lysine methylation in human tumorigenesis , 2015, Nature Reviews Cancer.
[26] S. Li,et al. Non-histone protein methylation as a regulator of cellular signalling and function , 2014, Nature Reviews Molecular Cell Biology.
[27] Scott M. Carlson,et al. Emerging technologies to map the protein methylome. , 2014, Journal of molecular biology.
[28] D. Busam,et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. , 2013, Cancer research.
[29] D. Patel,et al. A Poised Chromatin Platform for TGF-β Access to Master Regulators , 2011, Cell.
[30] C. Heldin,et al. Negative Regulation of TGFβ Signaling by the Kinase LKB1 and the Scaffolding Protein LIP1* , 2010, The Journal of Biological Chemistry.
[31] D. Franc,et al. SMAD4 Immunohistochemistry Reflects Genetic Status in Juvenile Polyposis Syndrome , 2010, Clinical Cancer Research.
[32] Hyun-A Seong,et al. Murine Protein Serine/Threonine Kinase 38 Stimulates TGF-β Signaling in a Kinase-dependent Manner via Direct Phosphorylation of Smad Proteins* , 2010, The Journal of Biological Chemistry.
[33] K. Helin,et al. Histone methyltransferases in cancer. , 2010, Seminars in cell & developmental biology.
[34] Samy Lamouille,et al. TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.
[35] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[36] S. Lens,et al. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis , 2008, Gut.
[37] Wei He,et al. Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ Pathway , 2006, Cell.
[38] K. Miyazono,et al. Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases* , 2005, Journal of Biological Chemistry.
[39] Jonathan G. Rud,et al. Nuclear Targeting of Transforming Growth Factor-β-activated Smad Complexes* , 2005, Journal of Biological Chemistry.
[40] M. Rugge,et al. Germ-Layer Specification and Control of Cell Growth by Ectodermin, a Smad4 Ubiquitin Ligase , 2005, Cell.
[41] R. Derynck,et al. Sumoylation of Smad4, the Common Smad Mediator of Transforming Growth Factor-β Family Signaling* , 2003, Journal of Biological Chemistry.
[42] F. Melchior,et al. Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4* , 2003, Journal of Biological Chemistry.
[43] C. Hill,et al. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.
[44] Takeo Iwama,et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.
[45] W. Bodmer,et al. Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[46] Yigong Shi,et al. A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.
[47] P. ten Dijke,et al. Targeting TGF-β Signaling in Cancer. , 2017, Trends in cancer.
[48] Xin-Hua Feng,et al. Phospho-control of TGF-β superfamily signaling , 2009, Cell Research.